Additional Supporting Information may be found in the online version of this article.

IJC_23985_sm_Suppfig1.tif1564KSupporting Figure 1 Allelic distribution of the JAK2V617F point mutation revealed by allele-specific QPCR. PCR product sequences (GATC) of the JAK2V617F locus (complementary sequence) of all PV-patients under study, of the cell line HEL (DSMZ, Braunschweig, Germany) as homozygote control and of one healthy individual. Additionally, results of allele-specific multi-QPCR with minor grove binder probes (Applied Biosystems) of the three allelic situations (A) homozygote JAK2V617F negative. Lower left picture: FAM-labeled amplification of the non-mutated allele with no amplification of mutated allele (linear graph). Lower middle picture: Half logarithmic graph. Lower right picture: linear graph of the VIC-labeled mutated PCR product (no amplification); (B) homozygote JAK2V617F positive; (C) heterozygote for JAK2V617F point mutation. All nine patients under study revealed a heterozygote mutational status of the highly purified CD34+ PBSC by QPCR and by PCR product sequencing.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.